NCT00002209View on ClinicalTrials.gov

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

Not specified

Conditions
AIDS Dementia ComplexHIV Infections
Interventions
DRUG

CPI-1189

Trial Locations (1)

85040

MDS Harris, Phoenix

Sponsors
All Listed Sponsors
lead

Centaur Pharmaceuticals

INDUSTRY